Parkinson's disease in the acute hospital

Clinical Medicine, Journal of the Royal College of Physicians of London

Volumn 11, Issue 1, 2011, Pages 84-88

  Jones, Sion L ^a   Hindle, John V ^a  

^a Llandudno LL30 1LB   (United Kingdom)

Author keywords

Delirium; Dysphagia; Falls; Palliative; Parkinson's disease

Indexed keywords

AMANTADINE; APOMORPHINE; BENSERAZIDE PLUS LEVODOPA; CARBIDOPA PLUS LEVODOPA; DOMPERIDONE; FLUDROCORTISONE; QUETIAPINE; RIVASTIGMINE; ROTIGOTINE; ANTIPARKINSON AGENT; NEUROLEPTIC AGENT;

ANESTHESIA; ARTICLE; ARTIFICIAL VENTILATION; BRAIN DEPTH STIMULATION; DELIRIUM; DEMENTIA; DRUG DELIVERY SYSTEM; DYSKINESIA; DYSPHAGIA; FALLING; HALLUCINATION; HUMAN; HYDRATION; HYPERPYREXIA; MENTAL DETERIORATION; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; PHYSIOTHERAPY; PSYCHOSIS; SWALLOWING; TERMINAL CARE; EMERGENCY HEALTH SERVICE; METHODOLOGY; PROGNOSIS; REVIEW;

ANTIPARKINSON AGENTS; ANTIPSYCHOTIC AGENTS; DEEP BRAIN STIMULATION; EMERGENCY SERVICE, HOSPITAL; HUMANS; PARKINSON DISEASE; PROGNOSIS;

EID: 79958059009     PISSN: 14702118     EISSN: 14734893     Source Type: Journal    
DOI: 10.7861/clinmedicine.11-1-84     Document Type: Article

References (35)

1. de Rijk MC, Launer LJ, Berger K et al. Prevalence of Parkinson's disease in Europe: a collaborative study of population- based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000;54(Suppl 5):S21-3.
2. Magdalinou KN, Martin A, Kessel B. Prescribing medications in Parkinson's disease (PD) patients during acute admissions to a District General Hospital. Parkinsonism Relat Disord 2007;13:539-40. (Pubitemid 350102299)
3. National Institute for Health and Clinical Excellence. Parkinson's disease. National clinical guideline for diagnosis and management in primary and secondary care. London: NICE, 2006.
4. Going into hospital. www.parkinsons.org. uk/advice/publications/going- into-hospital.aspx
5. Potulska A, Friedman A, Królicki L, Spychala A. Swallowing disorders in Parkinson's disease. Parkinsonism Relat Disord 2003;9:349-53. (Pubitemid 36809036)
6. Edwards LL, Quigley EM, Pffeifer RF. Gastrointestinal dysfunction in Parkinson's disease: frequency and pathophysiology. Neurology 1992;42:726-32.
7. Royal College of Physicians. Oral feeding difficulties and dilemmas. A guide to practical care, particularly towards the end of life. Report of a Working Party. London: RCP, 2010.
8. Monte FS, da Silva-Júnior FP, Braga-Neto P, Nobre e Souza MA, de Bruin VM. Swallowing abnormalities and dyskinesia in Parkinson's disease. Mov Disord 2005;20:457-62. (Pubitemid 40779020)
9. Dafotakis M, Sparing R, Juzek A, Block F, Kosinski CM. Transdermal dopaminergic stimulation with rotigotine in Parkinsonian akinetic crisis. J Clin Neurosci 2009;16:335-7.
10. Korczyn AD, Reichmann H, Boroojerdi B, Häck HJ. Rotigotine transdermal system for perioperative administration. J Neural Transm 2007;114:219-21. (Pubitemid 46147159)
11. Nicholson G, Pereira AC, Hall GM. Parkinson's disease and anaesthesia. Br J Anaesth 2002;89:904-16. (Pubitemid 35460530)
12. Anaesthesia and Parkinson's. www.parkinsons.org.uk/pdf/FS36- AnaesthesiaandParkinsons.pdf
13. Newman EJ, Grosset DG, Kennedy PG. The parkinsonism-hyperpyrexia syndrome. Neurocrit Care 2009;10:136-40.
14. Onofrj M, Thomas A. Acute akinesia in Parkinson disease. Neurology 2005;64:1162-9.
15. Takubo H, Harada T, Hashimoto T et al. A collaborative study on the malignant syndrome in Parkinson's disease and related disorders. Parkinsonism Relat Disord 2003;9(Suppl 1):S31-41.
16. Tackenberg B, Möller JC, Eggert K, Sommer N, Oertel WH. Akinetic crisis caused by rectus sheath hematoma and acute anaemia due to subcutaneous administration of apomorphine. Mov Disord 2006;21:126-7. (Pubitemid 43273771)
17. Sato Y, Asoh T, Metoki N, Satoh K. Efficacy of methylprednisolone pulse therapy on neuroleptic malignant syndrome in Parkinson's disease. J Neurol Neurosurg Psychiatry 2003;74:574-6.
18. Meagher LJ, McKay D, Herkes GK, Needham M. Parkinsonism-hyperpyrexia syndrome: the role of electroconvulsive therapy. J Clin Neurosci 2006;13:857-9. (Pubitemid 44415487)
19. Thomas A, Iacono D, Luciano AL, Armellino K, Onofrj M. Acute akinesia or akinetic crisis in Parkinson's disease. Neurol Sci 2003;24:219-20. (Pubitemid 37304322)
20. Allcock LM, Rowan EN, Steen IN et al. Impaired attention predicts falling in Parkinson's disease. Parkinsonism Relat Disord 2009;15:110-5.
21. Mostile G, Jankovic J. Treatment of dysautonomia associated with Parkinson's disease Parkinsonism Relat Disord 2009;15(Suppl 3):S224-32.
22. Pozzoni P, Tentori F, Corti M, Pozzi C. Rhabdomyolysis as a complication of Parkinson's disease. G Ital Nefrol 2002;19:13-7. [In Italian]
23. Jankovic J, Stacy M. Medical management of levodopa-associated motor complications in patients with Parkinson's disease. CNS Drugs 2007;21:677-92. (Pubitemid 47121793)
24. Hely MA, Morris JG, Reid WG, Trafficante R. Sydney Multicenter Study of Parkinson's disease: non-L-dopa responsive problems dominate at 15 years. Mov Disord 2005;20:190-9. (Pubitemid 40361122)
25. Hindle J, Playfer J. Parkinson's disease in the older patient, 2nd edn. Oxford: Radcliffe Publishing, 2008.
26. Pollak P, Tison F, Rascol O et al. Clozapine in drug induced psychosis in Parkinson's disease: a randomised, placebo controlled study with open follow up. J Neurol Neurosurg Psychiatry 2004;75:689-95. (Pubitemid 38526677)
27. Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA 2005;294:1934-43. (Pubitemid 41464695)
28. Emre M, Aarsland D, Albanese A et al. Rivastigmine for dementia associated with Parkinson's disease. N Engl J Med 2004;351:2509-18. (Pubitemid 39603164)
29. Resnick AS, Foote KD, Rodriguez RL et al. The number and nature of emergency department encounters in patients with deep brain stimulators. J Neurol 2010;257:122-31. [Erratum: J Neurol 2010;257:158-9]
30. Devos D; French DUODOPA Study Group. Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease. Mov Disord 2009;24:993-1000.
31. Snell K, Pennington S, Lee M, Walker R. The place of death in Parkinson's disease. Age Ageing 2009;38:617-9.
32. Hudson PL, Toye C, Kristjanson LJ.Would people with Parkinson's disease benefit from palliative care? Palliat Med 2006;20:87-94.
33. Christie J. The use of transdermal rotigotine in a patient with advanced Parkinson's disease and dysphagia. Palliat Med 2007;21:163-4. (Pubitemid 46455847)
34. Dewhurst F, Lee M, Wood B. The pragmatic use of apomorphine at the end of life. Palliat Med 2009;23:777-9.
35. Woodford H, Walker R. Emergency hospital admissions in idiopathic Parkinson's disease. Mov Disord 2005;20:1104-8. (Pubitemid 41632195)